Airway gene-expression classifiers for respiratory syncytial virus (RSV) disease severity in infants
Department
Medicine
Document Type
Article
Publication Title
BMC Medical Genomics
Abstract
Background: A substantial number ofinfants infected withRSV develop severe symptoms requiring hospitalization. We currently lack accurate biomarkers that are associated with severeillness.
Method: We definedairwaygeneexpression profiles based on RNA sequencing from nasal brush samples from 106 full-tem previously healthyRSV infected subjects during acute infection (day 1-10 ofillness) and convalescence stage (day 28 ofillness). All subjects were assigned a clinicalillnessseverity score (GRSS). Using AIC-based model selection, we built a sparse linear correlate of GRSS based on 41 genes (NGSS1). We also built an alternate model based upon 13 genes associated with severe infection acutely but displaying stableexpression over time (NGSS2).
Results: NGSS1 is strongly correlated with thediseaseseverity, demonstrating a naïve correlation (ρ) of ρ = 0.935 and cross-validated correlation of 0.813. As a binaryclassifier (mild versus severe), NGSS1 correctlyclassifiesdiseaseseverity in 89.6% of the subjects following cross-validation. NGSS2 has slightly less, but comparable, accuracy with a cross-validated correlation of 0.741 andclassification accuracy of 84.0%.
Conclusion: Airwaygeneexpression patterns, obtained following a minimally-invasive procedure, have potential utility for development of clinically useful biomarkers that correlate withdiseaseseverity in primaryRSV infection.
First Page
57
DOI
10.1186/s12920-021-00913-2.
Volume
14
Issue
1
Publication Date
2-25-2021
Recommended Citation
Wang, L., Chu, C., McCall, M. N., Slaunwhite, C., Holden-Wiltse, J., Corbett, A., Falsey, A. R., Topham, D. J., Caserta, M. T., Mariani, T. J., Walsh, E. E., & Qiu, X. (2021). Airway gene-expression classifiers for respiratory syncytial virus (RSV) disease severity in infants. BMC Medical Genomics, 14 (1), 57. https://doi.org/10.1186/s12920-021-00913-2.